Wiley Blackwell

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Brennan
    Brennan
  3. Motzer
    Motzer
  4. Shah
    Shah
  5. Danishefsky
    Danishefsky
  6. Russo
    Russo
  7. Shaha
    Shaha
  8. Vickers
    Vickers
  9. Eastham
    Eastham
  10. Mulhall
    Mulhall

Groups

  1. Department of Medicine (1520)
  2. Surgery (1224)
  3. Solid Tumor Oncology Division (883)
  4. Survivorship Research (806)
  5. GSK Faculty (664)
  6. Sloan Kettering Institute Faculty (622)
  7. Population Sciences Research Program (614)
  8. Department of Pathology and Laboratory Medicine (533)
  9. Epidemiology and Biostatistics (484)
  10. Center for Hematologic Malignancies (432)
Search Within
Formats
  1. Journal Article (3486)
  2. Meeting Abstract (680)
  3. Review (197)
  4. Conference Paper (94)
  5. Book Section (91)
  6. Editorial (90)
  7. Research Letter (34)
  8. Correspondence (25)
  9. Guidelines (23)
  10. Miscellaneous (6)
  11. Book Whole (3)
Groups
  1. Department of Medicine (1520)
  2. Surgery (1224)
  3. Solid Tumor Oncology Division (883)
  4. Survivorship Research (806)
  5. GSK Faculty (664)
  6. Sloan Kettering Institute Faculty (622)

More Groups

People
  1. Harry Herr (91)
  2. Murray Brennan (86)
  3. Robert Motzer (86)
  4. Jatin Shah (77)
  5. Samuel Danishefsky (74)
  6. Ashok Shaha (71)

More People

Years
  1. 2025 (80)
  2. 2024 (195)
  3. 2023 (264)
  4. 2022 (187)
  5. 2021 (221)
  6. 2020 (183)

More Years

Publications
  1. Cancer (1449)
  2. Journal of Surgical Oncology (368)
  3. BJU International (332)
  4. Hematological Oncology (199)
  5. Histopathology (151)
  6. EMBO Journal (131)

More Publications

Results (4729)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Daratumumab and EPOCH for HIV+/‐ plasmablastic lymphoma: A feasibility study of the AIDS Malignancy Consortium (AMC 105)
    Meeting Abstract

    Noy, A.; Barta, S. K.; Tan, C. R.; Kwon, D.; Baiocchi, R.; Rubinstein, P.; Ambinder, R.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 1 trail of KT‐413, a degrader of IRAK4 and IMID substrates, in adult patients with relapsed or refractory B‐cell non‐Hodgkins's lymphomas
    Meeting Abstract

    Lue, J. K.; Stevens, D. A.; Ayers, E.; Dunleavy, K.; Mattour, A.; Mishkin, A.; McDonald, A.; Agarwal, S.; Henrick, P.; Perea, R.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Lymph node and skin scoring growth kinetics predict outcomes in cutaneous T‐cell lymphoma: An interim analysis
    Meeting Abstract

    Fahmy, L. M.; Yang, H. R.; Zhou, M.; Beylergil, V.; Schreidah, C. M.; Kwinta, B. D.; Schwartz, L. H.; Fojo, A. T.; Bates, S. E.; Geskin, L. J.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • ZUMA‐24: A phase 2, open-label study of axicabtagene ciloleucel in patients with relapsed/refractory large B‐cell lymphoma given outpatient with corticosteroids
    Meeting Abstract

    Leslie, L.; Tees, M.; Flinn, I. W.; Rodriguez, T. E.; Baird, J. H.; Deol, A.; Mead, M.; Bachier, C.; Rapoport, A. P.; McClune, B.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • A phase I study of split‐course bringing radiotherapy (SC‐BRT) prior to commercial CD19 CAR T‐cell therapies for patients with relapsed or refractory B‐cell lymphomas
    Meeting Abstract

    Imber, B. S.; Yahalom, J.; Palomba, M. L.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 1 study of PRT1419 (MCL1 inhibitor) as monotherapy or in combination with azacitidine or venetoclax in patients with relapsed/refractory myeloid or B‐cell malignancies
    Meeting Abstract

    Zuniga, R. R.; Nair, S.; Keiffer, G.; Ravandi‐Kashani, F.; Goldberg, A. D.; Traer, E.; Frenzel, L. P.; Röllig, C.; Savickas, G.; Sun, W.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Upfront radiation therapy for post-stem cell transplant multiple myeloma patients with oligo‐relapse/progressive disease: Factors associated with favorable outcomes
    Meeting Abstract

    Fregonese, B.; Dreyfuss, A.; Imber, B.; Yahalom, J.; Hajj, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Association between geriatric impairments and quality of life in older adults with lymphoma on oral targeted therapies: A one‐year prospective study
    Meeting Abstract

    Torka, P.; Akhtar, O.; Kaijar, T.; Wang, K.; Attwood, K.; Carozza, D.; Bouchard, E.; Ghione, P.; Cortese, M.; Wildes, T.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Primary hepatic lymphoma: Role of low-dose radiotherapy and paired literature review
    Meeting Abstract

    Ma, J.; Daou, R.; Eid, J. Bou; Lee, J.; Fregonese, B.; El‐Khoury, J.; Wijetunga, N. A.; Imber, B. S.; Yahalom, J.; Hajj, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Radiation therapy in the management of primary gastric diffuse large B‐cell lymphomas: Long-term outcomes of 82 patients
    Meeting Abstract

    Fregonese, B.; Schieffelin, L.; Lee, J.; Boe, L.; Imber, B.; Yahalom, J.; Hajj, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save